About
Cytokine-based Therapy
Areas of Focus
Categories
Biologics & Biopharmaceutical
Clinical Trials (9)
View allTotal Trials
9
As Lead Sponsor
1
As Collaborator
8
Total Enrollment
473
By Phase
PHASE2: 7PHASE1/PHASE2: 1PHASE1: 1
By Status
COMPLETED: 8RECRUITING: 1
Clinical Trials Pipeline9 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
Today
Hover over trial bars to see details
Recent Trials
NCT05153070Collaborator
Ciclosporin Followed by Low-dose IL-2 in Patients With Recently Diagnosed Type 1 Diabetes
PHASE2Recruiting
24 participants
Started: Sep 21, 2022 · Completed: Apr 21, 2028
NCT03970954Collaborator
Low-dose Interleukin-2 in Women With Unexplained Miscarriages
PHASE1/PHASE2Completed
18 participants
Started: Jan 5, 2021 · Completed: Mar 20, 2024
NCT04357444Collaborator
Low Dose of IL-2 In Acute Respiratory DistrEss Syndrome Related to COVID-19
PHASE2Completed
30 participants
Started: Oct 23, 2020 · Completed: Apr 5, 2021
NCT04133233Collaborator
Low Dose IL-2 Therapy in Patients With a Depressive Episode in the Course of a Bipolar Disorder
PHASE2Completed
15 participants
Started: Jun 15, 2020 · Completed: Jul 20, 2022
NCT03837093Collaborator
Low-dose IL-2 to the Kinetics of Regulatory T-cell in Healthy Volunteers
PHASE1Completed
40 participants
Started: Jun 6, 2019 · Completed: Nov 6, 2021
Locations (1)
Headquarters
Paris, France
Map
Loading map...